Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall
Recall #D-0540-2025 · 04/21/2025
Class II: Risk
Recall Details
- Recall Number
- D-0540-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Status
- Ongoing
- Date Initiated
- 04/21/2025
- Location
- Richmond, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 Vials
Reason for Recall
CGMP Deviations; potential temperature excursions due to transit delays
Product Description
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
Distribution Pattern
Within the U.S - OH, VA, FL.
Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office
- Class II: Risk 07/30/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/24/2025
- Class II: Risk 04/24/2025
View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.